The BioDistrict regulatory council finalized the thirty percent licensing fee increase on all sanctioned CRISPR 4.0 somatic edits yesterday afternoon. The stated goal was to fund enhanced safety monitoring for elective genetic modifications. By sunset, I was already receiving encrypted messages from three different unregulated clinics in the lower blocks announcing they were open for business. The council fundamentally misunderstands the economics of biological necessity.
Raising the cost of a sanctioned procedure does not eliminate the demand. It simply delegates the procedure to someone operating a customized bioreactor out of a reinforced shipping container. I visited one of these basement clinics a few hours ago. A young man was negotiating the price for a minor metabolic adjustment to process the synthetic proteins common in the lower sector food block. The practitioner was using a discarded sequence compiler that had clearly bypassed the safety governors. The young man could not afford the new fees at a licensed facility, so his only option was rolling the dice on a street-level gene splice.
We are dangerously close to repeating the regulatory failures that preceded the massive Southeast Asia gene therapy scandal of 2040. When you price the working class out of safe, monitored genetic health care, you guarantee an explosion of unstable biological drifts. The BioDistrict was supposed to be the global gold standard for bioethics. Instead, we are legislating the return of the worst public health hazards imaginable, all under the guise of bureaucratic caution.